Form 4: Abeona Therapeutics CEO Vishwas Seshadri Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Abeona Therapeutics CEO Vishwas Seshadri reports disposition of shares to cover tax obligations upon vesting of restricted stock.
Summary
- On October 16, 2024, Vishwas Seshadri, CEO of Abeona Therapeutics Inc., reported a transaction involving the disposition of 251 shares of common stock.
- The shares were surrendered to cover tax withholding obligations related to the vesting of restricted stock.
- The transaction was executed at a price of $6.54 per share.
- Following the transaction, Seshadri directly owns 903,887 shares of Abeona Therapeutics Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to tax obligations, and does not contain information that would significantly impact investor sentiment positively or negatively.
Industry Context
Form 4 filings are standard practice for reporting transactions by company insiders, providing transparency to investors about their trading activities.
Key Dates
| Date | Description |
|---|---|
| 10/16/2024 | Date of stock transaction (disposition of shares). |
| 10/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.